본문 바로가기

Role of Sirtuin 6 in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease

문서 유형
연구출판물 · 리뷰논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q3
저널
CURRENT ISSUES IN MOLECULAR BIOLOGY48(5) · #435 · 2026
피인용
Web of Science 0Scopus 0
FWCI (Scopus)
0
JCR IF
JCR 2024 3
ISSN
1467-3037

저자

  1. 김연수제1저자
  2. 황성환교신저자Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea; Pusan Natl Univ, Res Inst Drug Dev, Busan 46241, South Korea

초록

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease worldwide and arises from systemic metabolic dysregulation and insulin resistance. Despite its increasing prevalence, effective pharmacological interventions remain limited. Recent evidence has identified sirtuin 6 (SIRT6), an NAD+-dependent epigenetic regulator, as an important modulator of hepatic metabolic and stress-responsive pathways. This review summarizes current knowledge regarding the role of SIRT6 in liver physiology and MASLD pathogenesis. Accumulating evidence indicates that SIRT6 suppresses lipogenic transcriptional programs while enhancing mitochondrial oxidative capacity and fatty acid oxidation, thereby maintaining metabolic homeostasis. Beyond lipid metabolism, SIRT6 is implicated in the regulation of endoplasmic reticulum stress responses, inflammatory signaling, and chromatin accessibility, which are the processes that collectively influence hepatocellular injury and disease progression. In addition, emerging data suggest that SIRT6 modulates hepatic stellate cell activation and fibrogenic signaling pathways, thereby linking epigenetic regulation to the development of liver fibrosis. A reduction in hepatic SIRT6 expression and activity has been reported in metabolic disorders, including MASLD. We further discuss the therapeutic potential of targeting SIRT6, including the development of selective small-molecule activators and naturally derived compounds aimed at restoring SIRT6 activity. Together, the available evidence positions SIRT6 as an important regulatory node in MASLD and a promising candidate for future therapeutic intervention.

키워드

epigeneticshistone deacetylationhepatic lipogenesisfatty acid oxidationinflammationfibrosisDE-NOVO LIPOGENESISINSULIN-RESISTANCEENDOPLASMIC-RETICULUMDEACETYLASE SIRT6ER STRESSMACROPHAGE POLARIZATIONSTRUCTURAL BASISMESSENGER-RNAPROTEINGENE

식별자

Scopus EID
2-s2.0-105040053028
WoS UID
001774291600001